Search Results for:

Sort by: Relevance Date
286 - 300 of 917 Results

The clinical trial conundrum

Failing to resume clinical trials could present as many risks to certain patients as COVID-19
No Date

The AI-enabled digital twin for life sciences

An Artificial Intelligence (AI) enabled digital twin is a state-of-the-art simulation of a complex real-world system, enhancing predictive AI
No Date

Generics 2030: Three strategies to curb the downward spiral

By 2030, generics manufacturers will need to shift from the status quo and explore one of three avenues for change.
No Date

Managing risk and compliance in your SAP S/4HANA journey

Life sciences companies face unique governance, risks and compliance challenges when implementing SAP S/4HANA technology.
No Date

Biopharmaceuticals deal trends: What to expect in 2021

Competition for innovation will continue to drive deal making
No Date

COVID-19 strategy - Client success video

KPMG helps forge a path through the chaos of COVID
No Date

Getting integration right in biotech acquisitions

It takes a delicate balance of control and freedom to pursue innovation
No Date

KPMG Life Sciences

Experience in cell & gene therapies
No Date

ESG reporting – a new opportunity for CAOs

How Chief Accounting Officers can lean into the challenge to enhance their strategic roles
No Date

Managing life sciences channel partners

Improving distributor monitoring and compliance in an increasingly complex global life sciences market
No Date

“One-and-done” gene therapies

A near-term niche?
No Date

Research & Development Performance

How to spot leaders vs. laggards
No Date

Reenvisioning the power of technology risk management in healthcare

The rapid pace of technology disruption in the healthcare sector is bringing on new and more pervasive risks.
No Date

Thriving in an AI World: Healthcare insights

Healthcare organizations have opportunities to use artificial intelligence to improve productivity, reduce risk, and save lives.
No Date

Thriving in an AI World: Life Sciences insights

Life sciences companies have turned a corner in the wake of COVID-19 and are now looking toward a smarter, faster future.
No Date
286 - 300 of 917 Results: